Cagrilintide 5 mg + Semaglutide 5 mg

Original price was: $136.00.Current price is: $108.80.

Member Price: $87.04 Become a member →

Out of stock

...
99%+ purity guaranteed
USA Lab Verified

Become a Member and save 20% on Every Order. 

Become a Member

EMAIL US FOR WHOLESALE PRICING
Orders of $5,000 or more

Description

Description

Cagrilintide and Semaglutide is a dual-peptide research formulation designed for laboratory studies investigating integrated metabolic hormone signaling and receptor crosstalk. The blend combines two long-acting peptide analogues that act on distinct but interconnected endocrine pathways, making it suitable for experimental models focused on energy regulation, gastrointestinal signaling, and metabolic feedback mechanisms.

Semaglutide is studied as a glucagon-like peptide-1 (GLP-1) receptor agonist, used in research to examine GLP-1–mediated signaling related to gastric motility, pancreatic hormone secretion, and central metabolic regulation. Cagrilintide is a long-acting amylin analogue investigated for its interaction with amylin and calcitonin receptors, enabling exploration of pathways associated with gastric emptying dynamics, glucagon modulation, and appetite-related neuroendocrine signaling.

When evaluated together in experimental systems, the peptides allow researchers to examine dual-hormone and multi-receptor pathway integration, including coordinated GLP-1 and amylin receptor signaling under controlled laboratory conditions.

This product is supplied exclusively for scientific and laboratory research use. It is not intended for human or veterinary consumption, clinical investigation, diagnostic use, or therapeutic application.

Overview

Chemical Identity & Classification

  • Dual-peptide research blend 
  • GLP-1 receptor agonist + amylin analogue 
  • Metabolic and gastrointestinal signaling research compounds 

Why Researchers Study This Blend

  • To investigate combined GLP-1 and amylin receptor signaling 
  • To study receptor crosstalk in metabolic and gastrointestinal pathways 
  • To explore systems-level hormone signaling integration in experimental models 

Key Research Systems & Pathways

  • GLP-1 receptor–mediated signaling networks 
  • Amylin and calcitonin receptor pathways 
  • Gastric motility and gastrointestinal hormone signaling 

Metabolic feedback and endocrine coordination mechanisms

Research

Mechanistic Rationale

In preclinical research models, Semaglutide and Cagrilintide are studied together to assess how parallel peptide hormone pathways influence metabolic signaling coordination. Rather than acting through identical mechanisms, the peptides engage distinct receptor families, enabling investigation of additive or interactive effects on downstream signaling cascades, neuronal integration, and endocrine feedback regulation.

 

Cellular & Molecular Research

The blend is utilized in laboratory studies examining:

  • GLP-1 and amylin receptor activation dynamics 
  • Intracellular signaling cascades linked to hormone-responsive pathways 
  • Transcriptional and second-messenger responses to multi-receptor engagement
    All investigations are conducted in controlled in vitro or biochemical assay environments.
     

 

System-Level & Metabolic Research

Research applications may include:

  • Gastrointestinal signaling models 
  • Neuroendocrine integration studies 
  • Hormone-regulated metabolic pathway analysis
    These investigations remain exploratory and mechanistic, without therapeutic interpretation.
     

 

Experimental Models

  • In vitro receptor and signaling assays 
  • Ex vivo endocrine or gastrointestinal tissue studies 
  • Non-clinical in vivo preclinical research models 

All use is strictly limited to laboratory research contexts.

Research-Grade Purity & Format

  • Supplied as a lyophilized dual-peptide blend 
  • Verified ≥ 99 % purity by HPLC 
  • Designed for consistent handling and experimental reproducibility 
  • Reconstitutes readily in laboratory-grade aqueous buffers
FAQ 

What is the Cagrilintide + Semaglutide blend used for in research?
It is used in laboratory research to study combined GLP-1 and amylin receptor signaling, metabolic hormone integration, and gastrointestinal pathway regulation.

Which peptides are included in this formulation?
The blend contains Cagrilintide (2.5 mg) and Semaglutide (2.5 mg) as a combined research formulation.

What mechanisms are investigated using this blend?
Research focuses on GLP-1, amylin, and calcitonin receptor signaling, as well as multi-hormone pathway coordination.

Is this blend approved for human or clinical use?
No. This product is strictly for research use only and is not intended for human consumption, veterinary use, or clinical application.

How should this peptide blend be stored and handled?
It should be stored and handled according to standard laboratory peptide storage and handling practices to maintain stability and integrity.

Shipping & Delivery

Storage & Handling

All peptides are supplied as sterile, lyophilized powder and are stable when handled correctly.

  • On arrival: Store vials in a cool, dry place away from heat and direct sunlight.
  • Long-term (powder): For optimal longevity, keep lyophilized peptides refrigerated to help maintain integrity.
  • After reconstitution: Use an appropriate research diluent (for example, BAC water). Store the reconstituted solution in the refrigerator and use within 20–30 days for best stability.

Note: Minimize exposure to moisture and repeated freeze–thaw cycles. Follow your institution's safety procedures when handling research materials.

Peak Lab Peptides maintains quality-control processes and routinely performs third-party testing to support purity and identity verification. COAs are available upon request for applicable batches. Documentation may vary depending on production timelines.

We aim to make batch-level documentation available whenever possible. Our goal is to expand COA access across the full catalog as production capacity grows.

All products are for laboratory research use only and are not intended for human consumption.